Natural aminosterols inhibit <scp>NMDA</scp> receptors with low nanomolar potency

Giulia Fani, Elisabetta Coppi, Silvia Errico, Federica Cherchi, M. Gennari, Denise Barbut, Michele Vendruscolo, Michael Zasloff, Anna Maria Pugliese, Fabrizio ChitiFEBS 2025 · DOI

TL;DR

Researchers have discovered that natural aminosterols, like trodusquemine (TRO), are potent inhibitors of NMDA receptors (NMDARs), a key player in many brain disorders. These compounds bind directly to NMDARs with low nanomolar potency, offering a promising new avenue for therapeutic development.

What Problem Does This Paper Address?

N-methyl-D-aspartate receptors (NMDARs) are crucial for normal brain function, but their overactivation is implicated in a wide range of neurological and psychiatric disorders, including Alzheimer's, Parkinson's, epilepsy, and stroke. This makes NMDARs a prime target for drug development. While many NMDAR inhibitors exist, there's a continuous need for novel compounds with improved potency and potentially different mechanisms of action. This paper explores whether natural aminosterols, a class of compounds with a steroidal backbone, could serve as effective NMDAR inhibitors.

Methods

The study employed a multi-pronged approach:

  • Cellular Assays: They used cultured primary rat cortical neurons and human SH-SY5Y neuroblastoma cells to measure intracellular calcium ion (Ca²⁺) influx, a key indicator of NMDAR activation.
  • Fluorescence Resonance Energy Transfer (FRET): This technique was used to investigate direct physical interaction between NMDARs and trodusquemine (TRO). NMDARs were labeled with a fluorescent donor, and TRO with a fluorescent acceptor, to detect proximity.
  • Electrophysiology (Patch Clamp): This gold-standard technique was used to directly measure NMDA-induced ion currents in isolated rat hippocampal neurons to determine the precise inhibitory potency (IC₅0).
  • Mechanosensitivity Assays: They investigated whether TRO's effects were mediated by changes in cell membrane properties, using a fluorescent probe (TMA-DPH) to assess membrane fluidity.
  • Indirect Mechanism Screening: They tested hypotheses that TRO might inhibit NMDARs indirectly by affecting processes like endocytosis or by inhibiting other enzymes like PTP1B.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Natural Compounds as Potent Inhibitors: The discovery that naturally occurring aminosterols can potently inhibit NMDARs opens up a new class of potential therapeutic agents.
  • Direct Binding Mechanism: FRET experiments strongly suggest that TRO directly interacts with NMDARs, ruling out several indirect mechanisms. This direct interaction is key to understanding its potency.
  • Membrane Interaction is Crucial: The requirement for cell membrane pre-adsorption before TRO can inhibit NMDARs highlights the importance of TRO's interaction with the cell membrane as a prerequisite for its action on the receptor.
  • Structural Similarities Matter: The structural resemblance of aminosterols to known NMDAR inhibitors like PAS provided the initial hypothesis, which was then experimentally validated.
  • Potency Beyond Expectations: The IC₅₀ values for TRO are remarkably low, significantly outperforming many existing NMDAR inhibitors, especially those targeting similar binding sites.

Key Results

  • Calcium Influx Inhibition: Trodusquemine (TRO) effectively inhibited NMDA-induced Ca²⁺ influx in both primary neurons and neuroblastoma cells in a dose-dependent manner.
  • Low Nanomolar Potency: Electrophysiological recordings revealed that TRO inhibits NMDA-activated currents with an IC₅₀ of approximately 5.1 nM. This is about 5000-fold more potent than PAS and significantly more potent than many other known inhibitors targeting similar regions.
  • Direct Interaction Confirmed: FRET analysis demonstrated a close spatial proximity between TRO and NMDARs, indicating direct binding.
  • Indirect Mechanisms Ruled Out: Experiments ruled out NMDAR endocytosis, PTP1B inhibition, and cell membrane compression as the primary mechanisms of TRO's NMDAR inhibition.
  • ENT-03 Shows Similar Effects: Another natural aminosterol, ENT-03, also demonstrated inhibitory effects on NMDA-induced Ca²⁺ influx, suggesting this property is shared within the aminosterol class.
  • Broader Receptor Inhibition: TRO was also found to inhibit AMPA and kainate receptors, similar to PAS, suggesting a broader impact on ionotropic glutamate receptors.

Limitations and Future Work

  • Cellular vs. In Vivo: While the study shows potent inhibition in cell cultures and isolated neurons, further in vivo studies are needed to confirm these effects in a whole organism and assess therapeutic efficacy and safety.
  • Binding Site Specificity: While direct binding is established, the precise binding site on the NMDAR and the specific subunit interactions remain to be fully elucidated.
  • Heterogeneous Subunit Composition: The study acknowledges that NMDAR subunit composition can vary, which might influence drug responses. Future work could explore TRO's selectivity for different NMDAR subtypes.
  • Dosage and Optimization: The authors note that the potent inhibition might complicate dosage, suggesting that chemical optimization of aminosterols might be necessary for therapeutic applications.
  • Broader Therapeutic Potential: The inhibition of AMPA and kainate receptors, alongside NMDARs, suggests potential applications beyond NMDAR-related disorders, which warrants further investigation.

Summary updated

Abstract

Abnormal functions of N-methyl-D-aspartate receptors (NMDARs) are associated with many brain disorders, making them primary targets for drug discovery. We show that natural aminosterols inhibit the NMDAR-mediated increase of intracellular calcium ions in cultured primary neurons and neuroblastoma cells. Structural comparison with known NMDAR-negative allosteric modulators, such as pregnanolone-sulfate-2 (PAS), raises the hypothesis that aminosterols have the same mechanism of action. Fluorescence resonance energy transfer (FRET) measurements using labeled NMDAR and the labeled aminosterol trodusquemine (TRO) indicate close spatial proximity, likely arising from binding. Other indirect yet plausible mechanisms for NMDAR inhibition by TRO were excluded. Electrophysiological patch clamp measurements on primary neurons indicate that pre-incubated TRO inhibits NMDA-induced ion currents with a IC<sub>50</sub> of 5 nm. Inhibition is observed only after cell membrane pre-adsorption, indicating accessibility to NMDAR from the cell membrane and binding to the transmembrane domains (TMDs) and TMD-ligand-binding domain (LBD) linkers, similarly to PAS. The TRO IC<sub>50</sub> is 5000-fold higher than that of PAS and 20-16 000 times higher than those of other inhibitors binding to TMD/TMD-LBD regions, identifying aminosterols as promising and potent NMDAR modulators.
BibTeX
@inproceedings{fani2025natural,
  author = {Giulia Fani and Elisabetta Coppi and Silvia Errico and Federica Cherchi and M. Gennari and Denise Barbut and Michele Vendruscolo and Michael Zasloff and Anna Maria Pugliese and Fabrizio Chiti},
  title = {{Natural aminosterols inhibit <scp>NMDA</scp> receptors with low nanomolar potency}},
  booktitle = {FEBS},
  year = {2025},
  doi = {10.1111/febs.70072},
}
Figure